Loading…
Lobbying Spend
—
Filings
62
Firms Hired
1
Active Period
2013–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $80,000
Matched citations: H.R. 2821
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $80,000
Matched citations: S. 355
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $100,000
Matched citations: H.R. 2821
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $100,000
Matched citations: S. 355
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $110,000
Matched citations: H.R. 2821
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $110,000
Matched citations: S. 355
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $70,000
Matched citations: H.R. 2821
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $70,000
Matched citations: S. 355
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $70,000
Matched citations: H.R. 2821
SAFE Sunscreen Standards Act
2025 · fourth_quarter · Firm: HOLLAND & KNIGHT LLP
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $70,000
Matched citations: H.R. 3686
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: HOLLAND & KNIGHT LLP
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $70,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: HOLLAND & KNIGHT LLP
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $70,000
Matched citations: S. 2256
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Client expense: — · Firm income: $70,000
Matched citations: S. 355
SAFE Sunscreen Standards Act
2025 · third_quarter · Firm: HOLLAND & KNIGHT LLP
Reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 3686
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: HOLLAND & KNIGHT LLP
Reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: HOLLAND & KNIGHT LLP
Reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing.
Client expense: — · Firm income: $70,000
Matched citations: S. 2256
SAFE Sunscreen Standards Act
2025 · second_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).
Client expense: — · Firm income: $70,000
Matched citations: H.R. 3686
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · second_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).
Client expense: — · Firm income: $70,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · second_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).
Client expense: — · Firm income: $70,000
Matched citations: S. 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
2024 · fourth_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA).
Client expense: — · Firm income: $70,000
Matched citations: H.R. 9027
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
2024 · fourth_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA).
Client expense: — · Firm income: $70,000
Matched citations: S. 4690
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
2024 · third_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); skin cancer prevention for outdoor workers; Cancer Moonshot initiative; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA).
Client expense: — · Firm income: $70,000
Matched citations: H.R. 9027
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
2024 · third_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); skin cancer prevention for outdoor workers; Cancer Moonshot initiative; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA).
Client expense: — · Firm income: $70,000
Matched citations: S. 4690
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
2024 · second_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); implementation of the National Academies of Science (NAS) report on sunscreen; skin cancer prevention for outdoor workers; Cancer Moonshot initiative; use of sunscreen in schools to prevent sunburns in children.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 9027
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
2024 · second_quarter · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); implementation of the National Academies of Science (NAS) report on sunscreen; skin cancer prevention for outdoor workers; Cancer Moonshot initiative; use of sunscreen in schools to prevent sunburns in children.
Client expense: — · Firm income: $70,000
Matched citations: S. 4690
Source: Senate LDA